Panacea Biotec Quarterly Results for Trading Insights
PANACEABIO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-14 Cr
QSept 2025
Panacea Biotec Quarterly Results Key Highlights
- Revenue of ₹150 Cr in Sept 2025 (-11.2% vs Mar 2025, -3.2% vs Sept 2024)
- Net Profit of ₹-14 Cr in Sept 2025 (-600.0% vs Mar 2025, -380.0% vs Sept 2024)
- EBITDA of ₹-9 Cr in Sept 2025 (-200.0% vs Mar 2025)
- Operating Margin of -13.0% in Sept 2025 (+7.0pp vs Mar 2025)
- Earnings Per Share of ₹-2.27 in Sept 2025 (-632.3% vs Mar 2025)
Panacea Biotec Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 150 | 169 | 184 | 155 | 150 | -11.2% | -3.2% |
| Net Profit (₹ Cr) | -14 | -2 | 4 | 5 | -2 | - | - |
| EBITDA (₹ Cr) | -9 | 9 | 16 | 14 | 8 | - | - |
| EPS (₹) | -2.27 | -0.31 | 0.66 | 0.77 | -0.23 | - | - |
| Operating Margin (%) | -13.0% | -20.0% | -1.0% | 5.0% | -4.0% | - | - |
Panacea Biotec Share Price Trend Around Quarterly Results
Visualize Panacea Biotec's 1-year price movement across quarterly results — ideal for logging trades in Panacea Biotec share price
chart using Tickjournal. All values in ₹.
Related Pages for Panacea Biotec
Additional stock information and data for PANACEABIO
Revenue Trend (₹ Cr)
Sept 2024
155
Jun 2025
184
Mar 2025
169
Sept 2025
150
Net Profit Trend (₹ Cr)
Sept 2024
5
Jun 2025
4
Mar 2025
-2
Sept 2025
-14
Operating Margin Trend (%)
Sept 2024
5.0%
Jun 2025
-1.0%
Mar 2025
-20.0%
Sept 2025
-13.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Panacea Biotec quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores